Neoprobe gets go-ahead for Quantix/OR

Neoprobe has received Food and Drug Administration 510(k) clearance for its Quantix/OR intraoperative blood-flow measurement system. With the clearance, Neoprobe said it would begin clinical evaluation of Quantix/OR at U.S. institutions. Boston University Medical Center will be the first U.S. evaluation site for the system, according to Neoprobe of Dublin, OH.

By AuntMinnie.com staff writers
September 9, 2003

Related Reading

Neoprobe continues to trim losses, increases revenue, July 31, 2003

Neoprobe cuts loss, May 8, 2003

Neoprobe begins delivering Qauntix/OR, April 28, 2003

Neoprobe shows loss in 2002, February 20, 2003

Neoprobe launches Quantix, November 21, 2002

Copyright © 2003 AuntMinnie.com

Page 1 of 183
Next Page